Cotización FibroBiologics - FBLG

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

3.19

Postura de Compra

3.09

Postura de Venta

3.35

Volume Operado de la Acción

155,545

3.0548 Rango del Día 3.27

1.0779 Rango de 52 semanas 55.00

Capitalización de Mercado [m]

112.158M

Precio Anterior

3.14

Precio de Apertura

3.22

Hora

3.23

Última hora de negociación

17:26:05

Volumen financiero

US$ 493,118

Precio Promedio Ponderado

3.1703

Volumen promedio (3 m)

451,801

Acciones en circulación

35,159,125

Rendimiento del Dividendo

Ratio Precio/Utilidad

-5.89

Beneficio por acción (BPA)

-0.54

turnover

Beneficio neto

-19.06M

FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.fibrobiologics.com

Sede

Wilmington, Delaware, USA

Fundado

FibroBiologics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBLG. The last closing price for FibroBiologics was US$3.14. Over the last year, FibroBiologics shares have traded in a share price range of US$ 1.0779 to US$ 55.00.

FibroBiologics currently has 35,159,125 shares in issue. The market capitalisation of FibroBiologics is US$110.40 million. FibroBiologics has a price to earnings ratio (PE ratio) of -5.89.

Form 8-K - Current report

FibroBiologics Engages Southern Star Research as CRO in Australia

HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on...

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

HOUSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on...

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

HOUSTON, Sept. 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

HOUSTON, Aug. 20, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...

Form EFFECT - Notice of Effectiveness

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	3.19	3.4	2.5	750800	3.11153183	CS
4	1.46	84.3930635838	1.73	4.41	1.49	944566	3.3605208	CS
12	-1.01	-24.0476190476	4.2	5.62	1.0779	451801	3.17565236	CS
26	-7.74	-70.8142726441	10.93	13.59	1.0779	296120	4.70451574	CS
52	-26.81	-89.3666666667	30	55	1.0779	253139	5.5982034	CS
156	-26.81	-89.3666666667	30	55	1.0779	253139	5.5982034	CS
260	-26.81	-89.3666666667	30	55	1.0779	253139	5.5982034	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ZCMDZhongchao Inc	US$ 2.18 (62.08%)	4.61M
GSIWGarden Stage Ltd	US$ 1.59 (31.40%)	5.65M
CMTLComtech Telecommunications Corporation	US$ 5.00 (19.05%)	1.44M
GIGMGigaMedia Ltd	US$ 1.69 (16.55%)	589
ATNF180 Life Sciences Corporation	US$ 1.88 (11.90%)	998
ENSCEnsysce Biosciences Inc	US$ 0.2189 (-23.99%)	231.31k
ADTXAditxt Inc	US$ 0.1415 (-13.35%)	1.81M
HSCSHeart Test Laboratories Inc	US$ 4.51 (-13.10%)	29.87k
TBIOTelesis Bio Inc	US$ 2.84 (-12.07%)	93.26k
MFImF International Ltd	US$ 0.626 (-11.33%)	151.76k
XPONExpion360 Inc	US$ 0.0646 (-10.53%)	10.31M
INTCIntel Corporation	US$ 23.83 (-0.33%)	6.45M
GSIWGarden Stage Ltd	US$ 1.59 (31.40%)	5.65M
NVDANVIDIA Corporation	US$ 120.7215 (-0.56%)	4.8M
ZCMDZhongchao Inc	US$ 2.18 (62.08%)	4.61M